Understanding ovarian reserve testing: what your AMH can (and cannot) tell you

There is something unusually powerful about being given a number that appears to say something about your fertility.

Perhaps it is 1.9. Perhaps it is 11. Perhaps it is 32.

You may have gone into the appointment simply wanting more information and left thinking about time, motherhood, egg freezing, relationships, age, and decisions you had not expected to make yet.

This is one of the difficulties with ovarian reserve testing. The test itself measures something relatively specific. What we can come to believe it means is often much bigger.

AMH, or anti-Müllerian hormone, has become one of the most familiar markers used in fertility assessment. Alongside an antral follicle count (AFC), it can give clinicians useful information about ovarian reserve and help predict how the ovaries might respond to stimulation during IVF or egg freezing.

But AMH is not a fertility score.

It cannot tell you whether you will have a baby. It cannot directly measure the quality of your eggs. And it cannot tell you precisely how much reproductive time you have left.

Understanding what it does tell us can make the result much more useful — and perhaps a little less frightening.

WHAT DOES OVARIAN RESERVE TESTING ACTUALLY MEASURE?

Women are born with the lifetime supply of eggs they will have. That pool gradually declines over time.

We cannot simply look inside the ovaries and count every remaining egg, so clinicians use indirect markers to estimate what is called ovarian reserve.

AMH is one of them.

It is a hormone produced by cells surrounding small developing follicles in the ovaries. Broadly, higher AMH levels tend to be associated with a larger pool of these follicles and lower levels with a smaller pool.

An antral follicle count looks at something similar from another angle. During an ultrasound, the clinician counts the small follicles that can be seen within the ovaries at that point in the cycle.

Neither test is perfect. But together — and interpreted alongside your age, medical history and circumstances — they can give a useful picture of how the ovaries may respond if they are stimulated with fertility medication.

That last part matters.

Because ovarian reserve testing is much better at predicting how many eggs we might retrieve than predicting whether those eggs will ultimately result in a baby.

These are not the same question.

QUANTITY IS NOT THE SAME AS QUALITY

This is probably the most important distinction to understand.

AMH primarily tells us about quantity. It does not directly measure egg quality.

There is currently no simple blood test that can tell us the quality of the eggs sitting within the ovaries. Age remains one of the most important indicators we have when thinking about the likelihood of chromosomal abnormalities in eggs and, therefore, reproductive potential.

This means two women can have very different AMH results without the higher number automatically belonging to the person with the “better fertility”.

A younger woman with a relatively low AMH may produce fewer eggs during an egg-freezing cycle, but those eggs are still eggs from a younger ovary.

An older woman may have a reassuringly high AMH and produce more eggs during stimulation, but the AMH does not make those eggs biologically younger.

Both pieces of information matter. They simply tell us different things.

And perhaps this is where ovarian reserve testing becomes emotionally complicated. We naturally want one result to tell us where we stand.

Biology rarely offers us that kind of simplicity.

A LOW AMH DOES NOT MEAN YOU CANNOT GET PREGNANT

One of the most understandable leaps is to hear low ovarian reserve and translate it internally into low fertility.

The research does not support such a straightforward conclusion.

Studies of women trying to conceive naturally have found that diminished ovarian reserve markers do not reliably predict who will or will not become pregnant in the short term.

That may initially seem strange. If there are fewer eggs remaining, shouldn't pregnancy automatically become less likely?

But natural conception does not require the ovaries to produce ten or fifteen eggs at once. Usually, it requires one ovulated egg in a cycle, alongside functioning fallopian tubes, viable sperm, appropriate timing and many other pieces of reproductive biology coming together.

This is very different from IVF or egg freezing, where we deliberately stimulate the ovaries because we want multiple follicles to develop simultaneously.

In that setting, ovarian reserve becomes much more relevant.

Someone with a lower AMH may recruit fewer follicles and therefore retrieve fewer eggs in a stimulation cycle. Someone with a higher AMH may produce considerably more.

That can affect treatment planning. It can affect how many cycles somebody might consider. It can affect expectations.

But fewer eggs available during stimulation is not the same statement as being unable to conceive.

It is worth allowing that distinction to land.

SO WHAT DOES AMH MEAN IF YOU ARE THINKING ABOUT EGG FREEZING?

This is where AMH can be genuinely helpful.

If you are considering freezing your eggs, your clinician is trying to think about at least two related but separate things: how many eggs might reasonably be retrieved, and what reproductive potential those eggs may have in the future.

AMH and AFC can help with the first question.

Age matters enormously for the second.

This is why a conversation about egg freezing should never really stop at “your AMH is good” or “your AMH is low.”

A more useful conversation might be:

How old are you? What does your AFC look like alongside your AMH? What response might reasonably be expected from one stimulation cycle? What are your future plans? And if your expected egg yield is lower, what would that information mean for the choices available to you?

The HFEA is careful to emphasise that egg freezing should not be understood as an insurance policy. Freezing eggs can preserve reproductive possibilities, but it cannot guarantee a future baby.

An AMH result cannot make that promise either.

THE SEDUCTION OF THE “FERTILITY MOT”

There is a reason the idea of a fertility MOT is appealing.

We live with quite a lot of uncertainty around fertility, particularly during years when decisions about relationships, careers, finances and family do not necessarily arrive in the order we expected.

So the possibility of taking a test and finding out where we stand is enormously attractive.

But the language can imply a level of certainty that reproductive medicine cannot currently provide.

There is no blood test that can tell a 32-year-old:

You have exactly six years left.

There is no AMH result that can promise:

You will be able to become pregnant when you are ready.

And there is no single number below which motherhood suddenly becomes impossible.

This does not make ovarian reserve testing pointless. Quite the opposite.

It means the test becomes useful when we ask it the right question.

THE NUMBER IS INFORMATION, NOT A VERDICT

If your AMH is unexpectedly low, it may be important information.

It might change the conversation you have with a fertility specialist. If you are considering egg freezing, it may influence expectations around egg yield or whether you would contemplate more than one cycle. In some circumstances it may encourage you to think about reproductive plans sooner than you otherwise would have.

If your AMH is high, that is useful information too. It may suggest a stronger response to ovarian stimulation and, at particularly high levels, can be relevant when clinicians consider conditions such as polycystic ovary syndrome or the risk of excessive response to fertility medication.

And if your result sits comfortably within the expected range, that can be reassuring — while still not guaranteeing that conception will be straightforward in the future.

Perhaps the hardest part is accepting that reproductive information does not always remove reproductive uncertainty.

We often seek testing because uncertainty is uncomfortable. A number feels solid. Something we can hold onto.

But sometimes the number answers one question while, underneath it, we are asking another.

AMH can help us ask: How might my ovaries respond to stimulation?

It is much less able to answer:

Will I be able to have the family I imagine?

Those questions can feel almost identical when you are sitting in a fertility clinic.

Medically, they are not.

Understanding the difference is about allowing one piece of information to remain exactly that: one piece of a much larger reproductive picture.

A QUESTION TO CARRY WITH YOU

If you have had ovarian reserve testing — or are considering it — perhaps the most useful question might be:

What can this result genuinely tell me, at my age and in my circumstances — and what am I asking it to tell me that it cannot know?

That is often a much better place from which to make decisions.

SOURCES AND FURTHER READING

Practice Committee of the American Society for Reproductive Medicine. “Testing and interpreting measures of ovarian reserve: a committee opinion.” Fertility and Sterility, 2020.

Steiner, A.Z. and colleagues. “Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Reproductive Age Women.” JAMA, 2017; 318(14):1367–1376.

European Society of Human Reproduction and Embryology. ESHRE Guideline: Ovarian Stimulation for IVF/ICSI. Updated guideline.

Human Fertilisation and Embryology Authority. Egg freezing. Patient information and UK fertility-treatment guidance.

Human Fertilisation and Embryology Authority. Fertility treatment trends and figures. UK treatment and outcome data.

Broer, S.L. and colleagues. Research on ovarian reserve testing and prediction of ovarian response in assisted reproduction. Human Reproduction Update and related reproductive-medicine literature.

Evidence checked: August 2026.

Venus of Now provides general education and reflection. This article is not personalised medical advice and does not replace consultation with an appropriately qualified fertility or reproductive-health professional.